Articles
Title
Date Published
Pathophysiology of TRALI: current concepts.
June 1, 2007
Blood management issues using blood management strategies.
June 1, 2007
TRALI–definition, mechanisms, incidence and clinical relevance.
June 1, 2007
Alternatives to allogeneic blood transfusions.
June 1, 2007
Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia.
June 1, 2007
Allogeneic red blood cell transfusion: physiology of oxygen transport.
June 1, 2007
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist.
June 1, 2007
Perioperative use of anti-platelet drugs.
June 1, 2007
Physiologic transfusion triggers.
June 1, 2007
Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
June 1, 2007
Changes in red blood cell transfusion practice during the past two decades: a retrospective analysis, with the Mayo database, of adult patients undergoing major spine surgery.
June 1, 2007
Efficacy and safety of aprotinin use for reoperative valvular surgery.
June 1, 2007
Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS).
June 1, 2007
Evaluation of the topical hemostatic efficacy ansafety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.
June 1, 2007
Estimating the cost of blood: past, present, and future directions.
June 1, 2007
Staged repair for a chronic dissecting thoracic aortic aneurysm with no transfusion in a Jehovah’s Witness patient.
June 1, 2007
Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States.
June 1, 2007
Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology.
June 1, 2007
Efficacy of allogeneic red blood cell transfusions.
June 1, 2007
Volume Replacement Therapy during Major Orthopedic Surgery Using Voluven(R) (Hydroxyethyl Starch 130/0.4) or Hetastarch.
June 1, 2007